TSG101
Tumor susceptibility gene 101 protein
Also known as: TS101_HUMAN, TSG10, VPS23
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99816
- Gene
- TSG101
- Ensembl
- ENSG00000074319
- Chromosome
- 11
- Canonical length
- 390 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
390 residues, UniProt reviewed canonical sequence.
>Q99816|TSG101
1 MAVSESQLKK MVSKYKYRDL TVRETVNVIT LYKDLKPVLD SYVFNDGSSR ELMNLTGTIP
61 VPYRGNTYNI PICLWLLDTY PYNPPICFVK PTSSMTIKTG KHVDANGKIY LPYLHEWKHP
121 QSDLLGLIQV MIVVFGDEPP VFSRPISASY PPYQATGPPN TSYMPGMPGG ISPYPSGYPP
181 NPSGYPGCPY PPGGPYPATT SSQYPSQPPV TTVGPSRDGT ISEDTIRASL ISAVSDKLRW
241 RMKEEMDRAQ AELNALKRTE EDLKKGHQKL EEMVTRLDQE VAEVDKNIEL LKKKDEELSS
301 ALEKMENQSE NNDIDEVIIP TAPLYKQILN LYAEENAIED TIFYLGEALR RGVIDLDVFL
361 KHVRLLSRKQ FQLRALMQKA RKTAGLSDLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSG101 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 94 nTPM
- tongue: 78 nTPM
- esophagus: 67 nTPM
- kidney: 66 nTPM
- heart muscle: 64 nTPM
- choroid plexus: 63 nTPM
Single-cell type
- oocytes: 580 nCPM
- esophageal apical cells: 437 nCPM
- syncytiotrophoblasts: 407 nCPM
- neutrophils: 364 nCPM
- cytotrophoblasts: 251 nCPM
- early primary spermatocytes: 214 nCPM
Immune cell
- basophil: 189 nTPM
- eosinophil: 156 nTPM
- neutrophil: 124 nTPM
- non-classical monocyte: 115 nTPM
- total PBMC: 91 nTPM
- T-reg: 85 nTPM
Brain region
- white matter: 37 nTPM
- choroid plexus: 37 nTPM
- hypothalamus: 34 nTPM
- spinal cord: 33 nTPM
- cerebellum: 31 nTPM
- medulla oblongata: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 2
- DepMap mean gene effect
- -1.16
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome maturation
- cell division
- endosome to lysosome transport
- exosomal secretion
- extracellular transport
- keratinocyte differentiation
- macroautophagy
- membrane fission
- multivesicular body assembly
- negative regulation of cell population proliferation
- negative regulation of epidermal growth factor receptor signaling pathway
- negative regulation of epidermal growth factor-activated receptor activity
- negative regulation of transcription by RNA polymerase II
- positive regulation of exosomal secretion
- positive regulation of ubiquitin-dependent endocytosis
- positive regulation of viral budding via host ESCRT complex
- protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
- regulation of cell cycle
- regulation of cell growth
- regulation of extracellular exosome assembly
- regulation of MAP kinase activity
- ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
- viral budding
- viral budding via host ESCRT complex
- viral release from host cell
Molecular functions
- calcium-dependent protein binding
- DNA binding
- protein homodimerization activity
- protein-containing complex binding
- transcription corepressor activity
- ubiquitin binding
- ubiquitin protein ligase binding
- virion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin E2 variant, N-terminal
- Ubiquitin-conjugating enzyme/RWD-like
- ESCRT assembly domain
- UEV domain
- Steadiness box (SB) domain
- ESCRT-I complex UEV domain-containing protein
- Vps23 core domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSG101 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSG101 as an antibody target. Whether an autoantibody or antibody against TSG101 could matter depends on whether native TSG101 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSG101 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSG101 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...